Idexx Laboratories (IDXX) Payables (2009 - 2026)

Idexx Laboratories (IDXX) has reported Payables for 18 consecutive years, with $130.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Payables rose 8.23% year-over-year to $130.0 million; the TTM figure through Mar 2026 stood at $130.0 million (up 8.23% YoY), while the FY2025 annual figure was $110.4 million, down 3.33% from the prior year.
• Payables came in at $130.0 million for Q1 2026 at Idexx Laboratories, up from $110.4 million in the prior quarter.
• The five-year high for Payables was $130.0 million in Q1 2026, with the low at $107.7 million in Q2 2023.
• Average Payables over 5 years is $116.2 million, with a median of $116.6 million recorded in 2025.
• Across the five-year window, Payables jumped 38.66% in 2022 and fell 15.4% in 2023, its largest moves.
• Year by year, Payables stood at $110.2 million in 2022, then advanced by 0.38% to $110.6 million in 2023, then climbed by 3.22% to $114.2 million in 2024, then slipped by 3.33% to $110.4 million in 2025, then increased by 17.72% to $130.0 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $130.0 million, $110.4 million, and $122.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.